Companies & Industry »Company News»Company News Details
Company News Details

BSE   27 Nov 15 | 12:00 AM

410.85 6.25 (1.54%)
Mkt Price (Rs)   Chg Rs (Chg %)
Code: 532321
Face Value: N.A.

NSE   27 Nov 15 | 12:00 AM

411.15 6.4 (1.58%)
Mkt Price (Rs)   Chg Rs (Chg %)
1 Week : Rs 417.30 (-1.55%)
1 Month : Rs 425.85 (-3.52%)
1 Year : Rs 310.24 (32.43%)
change companytradenow

Cadila's stock rising: Credit Suisse

Reuters / 18 Jul 12 | 11:50 AM

Credit Suisse initiates coverage on Cadila Healthcare with an "outperform" rating and a target price of Rs 970.

Investment bank says the midcap drug maker has demonstrated "strong execution" in the United States, with a portfolio mix focusing on low competition products such as nasal sprays and injectable drugs.

USFDA approval of its facilities in Moraiya, part of Gujarat, will re-start new approvals of its drugs in the US market, Credit Suisse adds.

"Cadila is moving up the value-chain with the launch of difficult-to formulate products and its strong execution record provides multi-year growth visibility."


Company Price Gain (%)
Hindalco Inds.77.503.26
St Bk of India249.552.80
Larsen & Toubro1,363.802.23
ICICI Bank269.601.97

Online Portfolio

You can create Online Portfolio here using the below button.